Albiglutide Completed Phase 1 Trials for impaired kidney function / Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00938158A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
NCT00394030Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
NCT02660736Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects